These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 22900824)

  • 1. Urushiol detection using a profluorescent nitroxide.
    Braslau R; Rivera F; Lilie E; Cottman M
    J Org Chem; 2013 Jan; 78(2):238-45. PubMed ID: 22900824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allergic contact dermatitis caused by Lithraea molleoides and Lithraea brasiliensis: identification and characterization of the responsible allergens.
    Alé SI; Ferreira F; González G; Epstein W
    Am J Contact Dermat; 1997 Sep; 8(3):144-9. PubMed ID: 9249282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonal antibody ALG 991.
    Baldwin RW; Clegg JA; Curran AC; Austin EB; Khan T; Ma Y; Gunn B; Hudecz F; Byers VS; Lepoittevin JP; Price MR
    Arch Dermatol Res; 1999 Dec; 291(12):652-8. PubMed ID: 10651166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single dose parenteral hyposensitization to poison ivy urushiol in guinea pigs.
    Walker LA; Watson ES; elSohly MA
    Immunopharmacol Immunotoxicol; 1995 Aug; 17(3):565-76. PubMed ID: 8576546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomass and toxicity responses of poison ivy (Toxicodendron radicans) to elevated atmospheric CO2.
    Mohan JE; Ziska LH; Schlesinger WH; Thomas RB; Sicher RC; George K; Clark JS
    Proc Natl Acad Sci U S A; 2006 Jun; 103(24):9086-9. PubMed ID: 16754866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Poison Ivy, Oak, and Sumac Dermatitis: What Is Known and What Is New?
    Kim Y; Flamm A; ElSohly MA; Kaplan DH; Hage RJ; Hamann CP; Marks JG
    Dermatitis; 2019; 30(3):183-190. PubMed ID: 31045932
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Occupational poison ivy and oak dermatitis.
    Epstein WL
    Dermatol Clin; 1994 Jul; 12(3):511-6. PubMed ID: 7923948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rapid detection of urushiol allergens of Toxicodendron genus using leaf spray mass spectrometry.
    Tadjimukhamedov FK; Huang G; Ouyang Z; Cooks RG
    Analyst; 2012 Mar; 137(5):1082-4. PubMed ID: 22249516
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poison oak hyposensitization. Evaluation of purified urushiol.
    Epstein WL; Baer H; Dawson CR; Khurana RG
    Arch Dermatol; 1974 Mar; 109(3):356-60. PubMed ID: 4273614
    [No Abstract]   [Full Text] [Related]  

  • 10. In situ changes in the relative abundance of human epidermal cytokine messenger RNA levels following exposure to the poison ivy/oak contact allergen urushiol.
    Boehm KD; Yun JK; Strohl KP; Trefzer U; Häffner A; Elmets CA
    Exp Dermatol; 1996 Jun; 5(3):150-60. PubMed ID: 8840155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of poison ivy/oak allergic contact dermatitis with an extract of jewelweed.
    Long D; Ballentine NH; Marks JG
    Am J Contact Dermat; 1997 Sep; 8(3):150-3. PubMed ID: 9249283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro studies of poison oak immunity. I. In vitro reaction of human lymphocytes to urushiol.
    Byers VS; Epstein WL; Castagnoli N; Baer H
    J Clin Invest; 1979 Nov; 64(5):1437-48. PubMed ID: 315414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy of the saponin component of Impatiens capensis Meerb.in preventing urushiol-induced contact dermatitis.
    Motz VA; Bowers CP; Kneubehl AR; Lendrum EC; Young LM; Kinder DH
    J Ethnopharmacol; 2015 Mar; 162():163-7. PubMed ID: 25543019
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toxicodendron dermatitis: poison ivy, oak, and sumac.
    Gladman AC
    Wilderness Environ Med; 2006; 17(2):120-8. PubMed ID: 16805148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunologic studies of poisonous Anacardiaceae: I. Production of tolerance and desensitization to poison Ivy and oak urushiols using esterified urushiol derivatives in guinea pigs.
    Watson ES; Murphy JC; Wirth PW; Waller CW; Elsohly MA
    J Invest Dermatol; 1981 Mar; 76(3):164-70. PubMed ID: 6453903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analogues of poison ivy urushiol. Synthesis and biological activity of disubstituted n-alkylbenzenes.
    ElSohly MA; Adawadkar PD; Benigni DA; Watson ES; Little TL
    J Med Chem; 1986 May; 29(5):606-11. PubMed ID: 2939241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation and Management of Toxicodendron Dermatitis in the Emergency Department: A Review of Current Practices.
    Argo KA; Massey RC; Luth SK; Herrington JM; Lane AQ; Murray KA
    Wilderness Environ Med; 2023 Sep; 34(3):388-392. PubMed ID: 37120383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of poison ivy and poison oak allergic contact dermatitis by quaternium-18 bentonite.
    Marks JG; Fowler JF; Sheretz EF; Rietschel RL
    J Am Acad Dermatol; 1995 Aug; 33(2 Pt 1):212-6. PubMed ID: 7622647
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro studies of poison oak immunity. II. Effect of urushiol analogues on the human in vitro response.
    Byers VS; Castagnoli N; Epstein WL
    J Clin Invest; 1979 Nov; 64(5):1449-56. PubMed ID: 315415
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.